Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
The Journal of Urology|April 28, 2016
9-Month Efficacy and Safety Study of Testosterone Solution 2% for Sex Drive and Energy in Hypogonadal MenGerald Brock, Darell Heiselman, Jack Knorr, et al.The Journal of Sexual Medicine|July 21, 2016
Impact of Testosterone Solution 2% on Ejaculatory Dysfunction in Hypogonadal MenMario Maggi, Darell Heiselman, Jack Knorr, et al.The Journal of Sexual Medicine|June 23, 2016
Demographic and Clinical Correlates of Patient-Reported Improvement in Sex Drive, Erectile Function, and Energy With Testosterone Solution 2Frederick Wu, Michael Zitzmann, Darell Heiselman, et al.Trials|October 22, 2021
Innovative clinical trial design and delivery: a phase 3 COVID-19 post-exposure prophylaxis study in skilled nursing and assisted living facilities (BLAZE-2)Jack Knorr, Jay L Tuttle, Janelle A Sabo, et al.Journal of Medical Virology|June 17, 2020
A cross-sectional community-based observational study of asymptomatic SARS-CoV-2 prevalence in the greater Indianapolis areaKristin J Meyers, Meghan E Jones, Iris A Goetz, et al.The Journal of Urology|October 27, 2015
Effect of Testosterone Solution 2% on Testosterone Concentration, Sex Drive and Energy in Hypogonadal Men: Results of a Placebo Controlled StudyGerald Brock, Darell Heiselman, Mario Maggi, et al.Journal of Medical Virology|January 19, 2021
Follow-up of SARS-CoV-2 positive subgroup from the Asymptomatic novel CORonavirus iNFection studyKristin J Meyers, Brian Dillman, Charles Williams, et al.Nature Communications|May 1, 2025
Ucenprubart is an agonistic antibody to CD200R with the potential to treat inflammatory skin disease: preclinical development and a phase 1 clinical studyAnja Koester, Derrick R Witcher, Mark Lee, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 31, 2021
A Randomized, Placebo-Controlled Clinical Trial of Bamlanivimab and Etesevimab Together in High-Risk Ambulatory Patients With COVID-19 and Validation of the Prognostic Value of Persistently High Viral LoadMichael Dougan, Masoud Azizad, Bharat Mocherla, et al.JAMA|June 3, 2021
Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living Facilities: A Randomized Clinical TrialMyron S Cohen, Ajay Nirula, Mark J Mulligan, et al.Pageof 1